Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy

Mesenchymal Stem Cell Homing: The Devil Is in the Details

(2009) Jeffrey M. Karp et al.   Cell Stem Cell

Progress and Prospects: The design and production of plasmid vectors

(2009) D R Gill et al.   GENE THERAPY

Autologous Bone Marrow Stromal Cells Genetically Engineered to Secrete an IGF-I Receptor Decoy Prevent the Growth of Liver Metastases

(2009) Ni Wang et al.   MOLECULAR THERAPY

Transgene Expression Is Associated with Copy Number and Cytomegalovirus Promoter Methylation in Transgenic Pigs

(2009) Qingran Kong et al.   PLoS One

Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation

(2008) Tatyana B. Prigozhina et al.   EXPERIMENTAL HEMATOLOGY

Therapeutic potential of genetically modified mesenchymal stem cells

(2008) S Kumar et al.   GENE THERAPY

Advances in High-capacity Extrachromosomal Vector Technology: Episomal Maintenance, Vector Delivery, and Transgene Expression

(2008) Michele MP Lufino et al.   MOLECULAR THERAPY

Mesenchymal Stromal Cells Engineered to Express Erythropoietin Induce Anti-erythropoietin Antibodies and Anemia in Allorecipients

(2008) Philippe M Campeau et al.   MOLECULAR THERAPY

Nonvirally Modified Autologous Primary Hepatocytes Correct Diabetes and Prevent Target Organ Injury in a Large Preclinical Model

(2008) Nelson K. F. Chen et al.   PLoS One

Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation

(2008) Volkert A. L. Huurman et al.   PLoS One

Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms

(2008) A Nasef et al.   Regenerative Medicine

2008 Update From the Collaborative Islet Transplant Registry

(2008) Rodolfo Alejandro et al.   TRANSPLANTATION